Hyaluronic Acid in Healthcare: Global Markets
商品番号 : SMB-87694
| 出版社 | BCC Research |
| 出版年月 | 2025年9月 |
| ページ数 | 114 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
ヒアルロン酸医療製品の世界市場は、2025年から2030年にかけて年平均成長率（CAGR）5.7%で成長し、2025年の80億ドルから2030年末までに105億ドルに成長すると予測されています。
ヒアルロン酸（HA）は、皮膚、眼、関節、結合組織に存在する天然のグリコサミノグリカンです。優れた保水力、組織の水分保持力、そして構造的サポート力で知られています。医療分野においては、関節の潤滑を目的とした整形外科、外科手術やドライアイ治療を目的とした眼科、美容整形や創傷治癒を目的とした皮膚科など、様々な分野でその重要性が高まっています。
本レポートは、ヒアルロン酸（HA）医療（ヘルスケア）製品の世界市場の概要を示すとともに、現在の市場動向を分析しています。本レポートで取り上げるHA医療製品には、ヒアルロン酸皮膚充填剤、粘性補充剤、ドライアイ治療薬、眼科用粘弾性デバイス（OVD）、創傷ケアおよび筋骨格修復のための再生医療製品、癒着防止バリア、泌尿器科用途の充填剤が含まれます。本レポートは、外来診療または外科手術において、資格のある医療専門家のみが使用または推奨できる処方薬のみを扱っています。
本レポートでは、HA医療製品市場の推定値として、2024年を基準年とする世界売上高（百万ドル）、2025年の推定値、そして2025年から2030年の予測期間のデータを掲載しています。本レポートは、市場およびベンダー環境における主要なトレンド、課題、そして機会に焦点を当てています。また、市場に関連する新製品、買収、提携についても取り上げています。さらに、環境、社会、コーポレートガバナンス（ESG）の動向についても分析しています。
Report Highlights
The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.
Summary:
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in the skin, eyes, joints and connective tissues. It is known for its remarkable ability to retain water, maintain tissue hydration and provide structural support. In healthcare, its importance extends across multiple fields, including orthopedics for joint lubrication, ophthalmology for surgical procedures and dry eye treatments and dermatology for aesthetic enhancements and wound healing.
Leading companies working in the domain of HA medical products include AbbVie Inc., Anika Therapeutics Inc., Bioventus, Fidia Farmaceutici, Galderma, IBSA Institut Biochimique SA, Sanofi and Seikagaku Corp.
Report Scope
This report offers an overview of the global market for hyaluronic acid (HA) medical (or healthcare) products while also analyzing current market trends. The HA medical products covered in this report include HA dermal fillers, viscosupplements, dry eye treatments, ophthalmic viscoelastic devices (OVDs), regenerative products for wound care and musculoskeletal repair, anti-adhesion barriers and bulking agents for urology applications. The report covers only prescription products that may be used or recommended exclusively by qualified healthcare professionals in outpatient settings or during surgical procedures.
The report’s estimates of the HA medical products market include global revenue ($ millions) for the base year of 2024, estimates for 2025 and data for the forecast period of 2025 through 2030. The report focuses on the major trends, challenges and opportunities in the market and vendor landscape. It also covers the new products, acquisitions and collaborations related to the market. The report also analyzes environmental, social and corporate governance (ESG) developments.
The report concludes with an analysis of the competitive landscape, which provides a ranking by market share of leading companies in each HA medical product market. There is also a section of profiles of the leading companies.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $7.6 Billion | ||||||||||||||||
| Market size forecast | $10.5 Billion | ||||||||||||||||
| Growth rate | CAGR of 5.7% from 2025 to 2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Product Type, HA Source, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America | ||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||
| Companies studied |
| ||||||||||||||||
Report Includes
– An overview of the global market for hyaluronic acid (HA) medical products
– In-depth analysis of global market trends, featuring historical revenue data from 2022-2024, estimated figures for 2025, as well as forecasts for 2030, including projections of compound annual growth rates (CAGRs) through 2030
– Analysis of market opportunities with a review of Porter’s Five Forces model and industry supply chain analysis, considering both micro- and macro environmental factors prevailing in the market
– Explanation of market drivers, restraints and other forces impacting the global market
– Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, regulatory framework and reimbursement scenarios, and ESG trends of the market
– Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, and strategic initiatives
– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
– A relevant patent analysis, featuring key granted and published patents
– Profiles of the leading global companies, including AbbVie Inc., Galderma, Sanofi, Bioventus, IBSA Institut Biochimique S.A., and Fidia Farmaceutici S.p.A.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Trends
Analysis by Segment
Analysis by Region
Conclusion
Chapter 2 Market Overview
Hyaluronic Acid
Analysis of Macroeconomic Factors
Economic Growth and Income Levels
Impact of the U.S. Tariffs
Demographic Trends
Porter’s Five Forces Analysis
Bargaining Power of Buyers: Moderate to High
Bargaining Power of Suppliers: Moderate
Threat of New Entrants: Moderate
Threat of Substitutes: Moderate to High
Industry Rivalry: Moderate
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Expanding Clinical Applications of Hyaluronic Acid
Innovation and Biotechnological Advancements
Trend Toward Minimally Invasive Procedures
Market Challenges
High Cost and Short-Lasting Effects of HA
Potential Adverse Reactions and Side Effects
Market Trends
Microbial Fermentation-based HA Production
Hybrid Formulations of HA
Chapter 4 Regulatory Landscape
Overview
U.S.
European Union
Japan
China
Chapter 5 Emerging Technologies and Developments
Hyaluronic Acid as a Drug Delivery Vehicle
Three-Dimensional Bioprinting
Enzyme-based Hyaluronic Acid Synthesis
Clinical Trial Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Product
Dermal Fillers
Viscosupplements
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Global Market for Hyaluronic Acid in Healthcare, by Source
Animal-derived HA
Microbial Fermentation
Geographic Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Region
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Hyaluronic Acid Dermal Fillers
Key Takeaways
Market Share Analysis
Viscosupplements
Key Takeaways
Market Share Analysis
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Chapter 8 Sustainability in Hyaluronic Acid Market: An ESG Perspective
Introduction to ESG
Key ESG Issues Specific to Hyaluronic Acid Market
Environmental Impact of Single-Use Plastics in HA-based Treatments
Environmental Challenges of Large-Scale Microbial HA Production
Critical Role of Quality Control in Injectable HA Safety
Concluding Remarks
Chapter 9 Appendix
Methodology
Information Sources
Abbreviations
Company Profiles
ABBVIE INC.
ANIKA THERAPEUTICS INC.
BIOVENTUS
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
GALDERMA
IBSA INSTITUT BIOCHIMIQUE SA
MEDYTOX
MERZ PHARMA
NORDIC PHARMA
SANOFI
SANTEN PHARMACEUTICAL CO. LTD.
SEIKAGAKU CORP.
TEOXANE
URSAPHARM ARZNEIMITTEL GMBH
Emerging Start-ups/Market Disruptors
List of Tables
Summary Table : Global Market for Hyaluronic Acid Medical Products, by Region, Through 2030
Table 1 : Global Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 2 : Global Nonsurgical Procedures Performed by Plastic Surgeons, 2022 versus 2023
Table 3 : Global Minimally Invasive Cosmetic Procedures, 2024 versus 2023
Table 4 : Commercially Available Hyaluronic Acid Dermal Fillers
Table 5 : Global Market for Dermal Fillers, by Region, Through 2030
Table 6 : Global Market for Viscosupplements, by Region, Through 2030
Table 7 : Commercially Available Three-Injection Regimen Viscosupplements
Table 8 : Commercially Available Single-Injection Regimen HA Viscosupplements
Table 9 : Commercially Available Five-Injection Regimen HA Viscosupplements
Table 10 : Global Market for Viscosupplements, by Regimen Type, Through 2030
Table 11 : Global Market for Ophthalmic Products, by Region, Through 2030
Table 12 : Global Market for Ophthalmic Products, by Type, Through 2030
Table 13 : Commercially Available Ophthalmic Viscosurgical Devices (OVDs)
Table 14 : Commercially Available Prescription Regenerative Solutions
Table 15 : Commercially Available Prescription Anti-Adhesion Products
Table 16 : Global Market for Regenerative and Anti-Adhesion Products, by Region, Through 2030
Table 17 : Commercially Available HA-Based Bulking Agents for Urology Applications
Table 18 : Global Market for Bulking Agents for Urology Applications, by Region, Through 2030
Table 19 : Medical Products Made of Animal-derived HA, 1997–2019
Table 20 : Global Market for Hyaluronic Acid Medical Products, by Hyaluronic Acid Source, Through 2030
Table 21 : Global Market for Hyaluronic Acid Medical Products, by Region, Through 2030
Table 22 : North American Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 23 : North American Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 24 : HA Injectable Aesthetic Procedures Performed, by Country, 2023
Table 25 : European Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 26 : European Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 27 : Asia-Pacific Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 28 : Asia-Pacific Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 29 : MEA Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 30 : South American Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 31 : Information Sources for this Report
Table 32 : Abbreviations Used in This Report
Table 33 : AbbVie Inc.: Company Snapshot
Table 34 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 35 : AbbVie Inc.: Product Portfolio
Table 36 : AbbVie Inc.: News/Key Developments, 2023 and 2024
Table 37 : Anika Therapeutics Inc.: Company Snapshot
Table 38 : Anika Therapeutics Inc.: Financial Performance, FY 2023 and 2024
Table 39 : Anika Therapeutics Inc.: Product Portfolio
Table 40 : Anika Therapeutics Inc.: News/Key Developments, 2023 and 2024
Table 41 : Bioventus: Company Snapshot
Table 42 : Bioventus: Financial Performance, FY 2023 and 2024
Table 43 : Bioventus: Product Portfolio
Table 44 : Bioventus: News/Key Developments, 2023
Table 45 : Ferring B.V.: Company Snapshot
Table 46 : Ferring B.V.: Financial Performance, FY 2023 and 2024
Table 47 : Ferring B.V.: Product Portfolio
Table 48 : Fidia Farmaceutici S.p.A.: Company Snapshot
Table 49 : Fidia Farmaceutici S.p.A.: Financial Performance, FY 2023 and 2024
Table 50 : Fidia Farmaceutici S.p.A.: Product Portfolio
Table 51 : Fidia Farmaceutici S.p.A.: News/Key Developments, 2023 and 2024
Table 52 : Galderma: Company Snapshot
Table 53 : Galderma: Financial Performance, FY 2023 and 2024
Table 54 : Galderma: Product Portfolio
Table 55 : Galderma: News/Key Developments, 2023 and 2024
Table 56 : IBSA Institut Biochimique SA: Company Snapshot
Table 57 : IBSA Institut Biochimique SA: Product Portfolio
Table 58 : IBSA Institut Biochimique SA: News/Key Developments, 2024
Table 59 : Medytox: Company Snapshot
Table 60 : Medytox: Financial Performance, FY 2023 and 2024
Table 61 : Medytox: Product Portfolio
Table 62 : Merz Pharma: Company Snapshot
Table 63 : Merz Pharma: Product Portfolio
Table 64 : Nordic Pharma: Company Snapshot
Table 65 : Nordic Pharma: Product Portfolio
Table 66 : Nordic Pharma: News/Key Developments, 2023–2025
Table 67 : Sanofi: Company Snapshot
Table 68 : Sanofi: Financial Performance, FY 2023 and 2024
Table 69 : Sanofi: Product Portfolio
Table 70 : Santen Pharmaceutical Co. Ltd.: Company Snapshot
Table 71 : Santen Pharmaceutical Co. Ltd.: Financial Performance, FY 2023 and 2024
Table 72 : Santen Pharmaceutical Co. Ltd.: Product Portfolio
Table 73 : Seikagaku Corp.: Company Snapshot
Table 74 : Seikagaku Corp.: Financial Performance, FY 2023 and 2024
Table 75 : Seikagaku Corp.: Product Portfolio
Table 76 : Seikagaku Corp.: News/Key Developments, 2024 and 2025
Table 77 : Teoxane: Company Snapshot
Table 78 : Teoxane: Product Portfolio
Table 79 : URSAPHARM Arzneimittel GmbH: Company Snapshot
Table 80 : URSAPHARM Arzneimittel GmbH: Product Portfolio
Table 81 : List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure : Global Market Shares of Hyaluronic Acid Medical Products, by Region, 2024
Figure 1 : Key Properties of Hyaluronic Acid
Figure 2 : Porter’s Five Forces Analysis – Hyaluronic Acid in Healthcare Market
Figure 3 : Market Dynamics for Hyaluronic Acid in Healthcare
Figure 4 : Active Clinical Trials for Hyaluronic Acid, by Indication Type, 2025
Figure 5 : Global Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 6 : Global Market Shares of Viscosupplements, by Regimen Type, 2024
Figure 7 : Global Market Shares of Ophthalmic Products, by Type, 2024
Figure 8 : Global Market Shares of Hyaluronic Acid Medical Products, by Hyaluronic Acid Source, 2024
Figure 9 : Global Market Shares of Hyaluronic Acid Medical Products, by Region, 2024
Figure 10 : North American Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 11 : North American Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 12 : European Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 13 : European Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 14 : Asia-Pacific Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 15 : Asia-Pacific Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 16 : MEA Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 17 : South American Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 18 : Global Market Shares of Hyaluronic Acid Dermal Fillers, by Company, 2024
Figure 19 : Global Market Shares of Viscosupplements, by Company, 2024
Figure 20 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
Figure 21 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
Figure 22 : Anika Therapeutics Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23 : Anika Therapeutics Inc.: Revenue Share, by Country/Region, FY 2024
Figure 24 : Bioventus: Revenue Share, by Business Unit, FY 2024
Figure 25 : Bioventus: Revenue Share, by Country/Region, FY 2024
Figure 26 : Ferring B.V.: Revenue Share, by Business Unit, FY 2024
Figure 27 : Ferring B.V.: Revenue Share, by Country/Region, FY 2024
Figure 28 : Fidia Farmaceutici S.p.A.: Revenue Share, by Business Unit, FY 2024
Figure 29 : Fidia Farmaceutici S.p.A.: Revenue Share, by Country/Region, FY 2024
Figure 30 : Galderma: Revenue Share, by Business Unit, FY 2024
Figure 31 : Galderma: Revenue Share, by Country/Region, FY 2024
Figure 32 : Medytox: Revenue Share, by Business Unit, FY 2024
Figure 33 : Medytox: Revenue Share, by Country/Region, FY 2024
Figure 34 : Sanofi: Revenue Share, by Business Unit, FY 2024
Figure 35 : Sanofi: Revenue Share, by Country/Region, FY 2024
Figure 36 : Santen Pharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 37 : Santen Pharmaceutical Co. Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 38 : Seikagaku Corp.: Revenue Share, by Business Unit, FY 2024
Figure 39 : Seikagaku Corp.: Revenue Share, by Country/Region, FY 2024
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
